First Trust Advisors LP cut its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 29.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 226,685 shares of the medical instruments supplier’s stock after selling 96,555 shares during the quarter. First Trust Advisors LP owned approximately 0.10% of DENTSPLY SIRONA worth $13,558,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Commonwealth Bank of Australia raised its position in shares of DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the period. Acrospire Investment Management LLC bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at about $113,000. Dupont Capital Management Corp bought a new position in shares of DENTSPLY SIRONA in the second quarter valued at about $116,000. Korea Investment CORP grew its stake in shares of DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after acquiring an additional 1,251 shares in the last quarter. Finally, Sphera Funds Management LTD. acquired a new position in shares of DENTSPLY SIRONA in the second quarter valued at about $162,000. 93.71% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/11/08/dentsply-sirona-inc-xray-shares-sold-by-first-trust-advisors-lp.html.

Several equities analysts recently commented on XRAY shares. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a research note on Thursday, July 13th. BidaskClub downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Wednesday, July 19th. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They issued a “buy” rating and a $74.00 price target on the stock. Credit Suisse Group restated an “outperform” rating and issued a $75.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Finally, Morgan Stanley restated an “overweight” rating and issued a $69.00 price target (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Three analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $67.00.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at $64.38 on Wednesday. The stock has a market cap of $14,658.28, a PE ratio of 25.45, a price-to-earnings-growth ratio of 2.62 and a beta of 1.27. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. DENTSPLY SIRONA Inc. has a one year low of $52.53 and a one year high of $67.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.66 by $0.04. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 earnings per share. equities analysts predict that DENTSPLY SIRONA Inc. will post 2.67 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.